Clinical trial
A Study on the Safety and Efficacy of BST08 in Treating Advanced Non-Small Cell Lung Cancer
NCT06643910 is registered in ClinicalTrials.gov with BioSyngen Pte Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study on the Safety and Efficacy of BST08 in Treating Advanced Non-Small Cell Lung Cancer
- Lead sponsor
- BioSyngen Pte Ltd
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 24, 2024
- Completion date
- August 31, 2027
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer